VISTAGEN THERAPEUTICS INC (VTGN)
US92840H4002 - Common Stock
| TTM (2023-12-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | 2020 (2020-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -32.07M | -59.25M | -47.76M | -17.93M | -20.77M | |||
| Depreciation Amortization | 124.50K | 130.00K | 150.00K | 120.00K | 100.00K | |||
| Change In Working Capital | 3.16M | 5.59M | -1.92M | 3.08M | -180.00K | |||
| Interest Paid | N/A | N/A | 0.00 | 10.00K | 10.00K | |||
| Taxes Paid | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 2.70M | 3.82M | 4.27M | 2.67M | 5.09M | |||
| OPERATING CASH FLOW | -26.10M | -49.72M | -45.26M | -12.07M | -15.76M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -32.30K | -210.00K | -200.00K | -280.00K | 0.00 | |||
| Other Investing Activity | N/A | -530.00K | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -562.30K | -740.00K | -200.00K | -280.00K | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.31M | -1.04M | 0.00 | -380.00K | -300.00K | |||
| Stock Issued/Repurchased | 93.53M | 170.00K | 6.45M | 114.48M | 4.31M | |||
| Other Financing Activity | 35.95M | -170.00K | 4.04M | N/A | N/A | |||
| FINANCING CASH FLOW | 128.17M | -1.04M | 10.48M | 114.10M | 4.01M | |||
| CHANGE IN CASH | 101.51M | -51.50M | -34.98M | 101.75M | -11.75M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -26.10M | -49.72M | -45.26M | -12.07M | -15.76M | |||
| Capital Expenditure | -32.30K | -210.00K | -200.00K | -280.00K | 0.00 | |||
| FREE CASH FLOW | -26.13M | -49.93M | -45.46M | -12.35M | -15.76M | |||
All data in USD